Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hydromorphone versus sufentanil PCIA after craniotomy
ChiCTR2600132000Phase 4Not yet recruiting
- Sponsor
- Affiliated Hospital of Guizhou Medical University
- Start
- Sep 2026
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of hydromorphone and sufentanil in postoperative pain (2 arms), sponsored by Affiliated Hospital of Guizhou Medical University. Primary endpoint: Numerical rating scale pain score. Planned start Sep 2026; status: not yet recruiting.
02
Drugs
hydromorphonesufentanil
03
Conditions
postoperative pain
Beyond the preview
Go deeper on ChiCTR2600132000.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2600132000.